Global Regulatory Updates for Life Sciences Companies

Recent Life Sciences Regulatory Updates

  • Saudi FDA Issues Guidance on Medical Device Bundling

    Saudi FDA medical device bundling MDS-G28 explains when device groupings may share one MDMA application and when separate submissions are needed.

    Read Full Insight

  • Malaysia and Thailand Implement Medical Device Regulatory Reliance Programme

    Malaysia–Thailand medical device reliance supports Class B, C, and D registrations through streamlined pathways between MDA and Thai FDA.

    Read Full Insight

  • Chile Expands Sanitary Control for Medical Devices and IVDs

    Chile medical device registration expands to 39 higher-risk devices and IVDs under Decree No. 25, with phased compliance through the ISP.

    Read Full Insight

  • FDA Signals 510(k) Relief for Additional Unclassified Devices

    FDA 510(k) exemption guidance adds five unclassified device codes to enforcement discretion while formal exemptions remain pending.

    Read Full Insight

  • UK MHRA Publishes Draft Pre-Market Requirements for Medical Devices and IVDs

    UK MHRA pre-market requirements propose changes to international reliance, UDI, implant cards, IVD classification, documentation, and device claims.

    Read Full Insight

AREAS OF FOCUS

Regulatory Topics Across the Product Lifecycle

RJR’s insights address developments that may affect product strategy, submissions, market entry, quality systems, and ongoing compliance across global markets.

Product Development & Regulatory Strategy

Early regulatory intelligence, pathway planning, classification, and market sequencing for products in development.

Submissions & Market Entry

Requirements affecting dossiers, registrations, health-authority interactions, local representation, and launch readiness.

Quality Systems & Compliance

Changes involving quality-management systems, manufacturing controls, audits, labeling, and ongoing compliance.

Post-Market & Lifecycle Management

Updates affecting surveillance, vigilance, product changes, renewals, corrective actions, and continued market access.

NEXT STEPS

Need Help Interpreting a Regulatory Change?

Share the market, product category, and regulatory development affecting your program. RJR can help assess its potential impact and identify the appropriate next steps.